Новости/Reuters/GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate…GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory Review26 нояб. 2022 г.00:12 UTCGSKGSK plc GSK:GSK CANADA SUBMITS RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE FOR REGULATORY REVIEW